MacroGenics | MGNX - أرباح التشغيل





أرباح التشغيل تغيير تاريخ
AbbVie USD 4.73B 1.08B 2026-03
Amgen USD 3.83B 130M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Biogen USD 514.3M 128.8M 2026-03
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Genmab DKK 260M 199M 2025-12
Geron USD -10.79M 3.1M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
J&J USD 6.62B 1.03B 2026-03
Karyopharm Therapeutics USD -17.84M 13.44M 2025-12
MacroGenics USD -12.1M 30.74M 2025-12
Merck USD -1.88B 8.12B 2026-03
Pfizer USD 4.99B 340M 2026-03
Puma Biotechnology USD 22.08M 24.26M 2024-09
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
Xencor USD -53.63M 6.11M 2025-12